In the current study, creatine kinase-MB was elevated in only three patients in the T2DM group and none in the non-T2DM group suggesting that the combined effect of DM and COVID-19 might have led to increased troponin T levels even in the absence of ischaemic injury. This evidence concerns the gene MB and COVID-19.